Marshall, “Gene Therapy's Growing Pains,” Science vol. 269, Aug. 25, 1995, pp. 1050-1055. |
Morgan, et al. “Human Gene Therapy,” Annual Rev. Bunhem. vol. 62 (1991) 217, pp. 191-217. |
Weiss, et al. (Ed.) “RNA Tumor Viruses,” Cold Spring Harbor Laboratory (1984) pp. 46-51 and 226-260. |
Te-Hua, et al., “Toward Highly Efficient Cell-Type-Specific Gene Transfer with Retroviral Vectors Displaying Single-Chain Antibodies,” Journal of Virology, vol. 71, 1997, pp. 720-725. |
Te-Hua, et al., “Retroviral Vector Particles Displaying the Antigen-Binding Site of an Antibody Enable Cell-Type-Specific Gene Transfer,” Journal of Virology, vol. 69 [1], 1995, pp. 2659-2663. |
Kewalramani, V.N., et al. “Spleen Necrosis Virus, an avian innunossupressive retrovirus, shares a receptor with the type D simian retroviruses”, Journal of Virology, vol. 66, No. 5, May 1992, pp. 3026-3031. |
Riley, S.C., et al. “Preferential expression of variable region heavy chain gene segments by predominant 2,4-dinitrophenyl-specific BALB/c neonatal antibody clonotypes,” Proceedings of the National Academy of Sciences of USA, vol. 83, No. 8, Apr. 1986, pp. 2589-2593. |
Russell, S.J. et al. “Retroviral vectors displaying functional antibody fragments,” Nucleic Acids Res. (1993), 21(5), pp. 1081-1085. |
Te-Hua, T.C., et al. “Cell targeting with retroviral vector particles containing antibody-envelope fusion proteins,” Gene Therapy, vol. 1, No. 5, Sep. 1994, pp. 292-299. |
Orkin et al., “Report and Recommendations of the Panel to Asses the NIH Investment in Research on Gene Therapy,” Dec. 7, 1995. |
Vera et al., Nature, vol. 389, pp. 239-242, Sep. 18, 1997. |